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Type 1 diabetes mellitus (T1DM) is among the most frequent 
chronic non-infectious diseases in children.[1] There appears to be 
a worldwide increase in T1DM in children and adolescents.[2] The 
incidence of T1DM is currently estimated at 5 new cases per 100 000 in 
the Western Cape, South Africa (SA), compared to 2 - 35 new cases 
per 100 000 worldwide.[3] 
Once a patient has been diagnosed with T1DM, it is important 
to gain adequate metabolic control to delay the onset and limit the 
progression of complications resulting from the disease.[4] To this 
end, the International Society for Pediatric and Adolescent Diabetes 
(ISPAD) recommends that a multidisciplinary diabetes care team 
(DCT) should be established, consisting of a diabetes specialist, 
a diabetes nurse educator (DNE), a dietitian and a social worker.[5,6] 
Including a DNE in the team has been shown to be effective in 
reducing the error rate in blood glucose measurements[7] and the 
duration of hospitalisation in both children and adults.[8-11] In adult type 
2 diabetes patients, marked improvements in glycated haemoglobin 
(HbA1c) levels have been observed after a DNE had participated 
in their routine diabetes care.[11-14] This result is supported by 
findings that showed a primary nurse practitioner succeeding in 
implementing the recommendations of the Diabetes Control and 
Complications Trial (DCCT) in paediatric diabetes patients within 1 
year, resulting in a significant decrease in HbA1c.[15] It has further been 
shown that a DNE’s regular telephone contact with poorly controlled 
T1DM patients had a delayed rather than an immediate beneficial 
effect.[16] A direct link between HbA1c levels and the number of visits 
to a DCT per year has been shown in the paediatric population.[17] 
In adult T1DM patients, onset of complications was delayed when 
specialist care was maintained after childhood[18] and a decrease 
in retinopathy and microalbuminuria has been demonstrated in 
adolescent patients irrespective of better glycaemic control.[19,20] The 
impact of management by a DNE or DCT on hospital admission and 
diabetic ketoacidosis (DKA) rates, especially in the paediatric age 
group, seems to be poorly documented. 
Tygerberg Children’s Hospital (TCH) introduced a DCT consisting 
of a paediatric endocrinologist, a dietitian and a social worker in August 
2007. Owing to financial constraints, a DNE could be appointed only 
in August 2009. It was hypothesised that the introduction of a full 
DCT for children and adolescents with T1DM at TCH would improve 
patients’ HbA1c levels, reduce hospital admission and DKA rates, and 
decrease the prevalence of complications.
Methods
Study design
This was a retrospective cohort study (with cross-sectional elements) 
of 190 T1DM children and adolescents attending the paediatric 
diabetes clinic at TCH, Cape Town, from August 2004 to July 2011. 
Participants were included if:
• they required insulin therapy after the neonatal period but before 
adolescence, irrespective of whether T1DM was confirmed 
on low serum C-peptide levels and elevated antiglutamic acid 
decarboxylase/islet antigen 2 antibodies
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• they were managed during the following periods: 
August 2004 - July 2005 (P1) – only a paediatric endocrinologist 
on site      
August 2007 - July 2008 (P2) – introduction of the DCT 
August 2009 - July 2010 (P3) – DNE included in the team 
September 2010 - July 2011 (P4) –DNE changed.
Patients with type 2, neonatal or monogenetic diabetes were excluded 
from the study.
The diabetes care team
The paediatric endocrinologist, registrar and intern were primarily 
responsible for the medical care of each patient, while the DNE 
educated the patients about diabetes and trained them in the 
necessary skills for managing the condition. The dietitian provided 
dietetic input. The social worker intervened whenever social or 
behavioural issues were identified. Patients were seen at least 4 times 
per year.
Data collection
The hospital records of the identified patients were reviewed to 
capture the following data: age; sex; age at diagnosis; ethnicity; types 
of insulin; number of injections per day; insulin dose; mean HbA1c 
level at the end of each period; hospital admissions due to DKA or 
poor control; prevalence of DKA and recurrent DKA (rDKA); mean 
urine albumin–creatinine ratio (UAC) at the end of each period; 
presence of retinopathy, neuropathy and limited joint mobility 
(LJM); fasting total serum cholesterol; low-density lipoprotein 
(LDL) cholesterol; high-density lipoprotein (HDL) cholesterol; and 
triglycerides. The cholesterol and triglyceride levels were categorised 
as high or normal according to Mayo Clinic criteria.[21]
Complication assessment was performed annually, starting 5 years 
after onset of T1DM in prepubertal patients and 2 years after onset 
of T1DM in pubertal patients. Microalbuminuria was defined by a 
UAC level >2 mg/mmol in two early-morning urine samples (taken at 
consecutive clinic visits). Retinopathy was initially confirmed visually 
by an ophthalmologist, but replaced by fundal photography from 
P4. Neuropathy was initially tested for by assessing pain and touch 
sensation. Vibration sense testing was introduced late in P3. LJM was 
determined qualitatively according to the prayer manoeuvre. 
Glycated haemoglobin measurements
Before 2009, HbA1c levels were measured by the local laboratory 
using an assay standardised to the DCCT assay and certified by the 
National Glycohemoglobin Standardization Program. From 2009, 
HbA1c levels were analysed with the DCA Vantage Analyzer point-
of-care device (Siemens, USA). The results of the two methods were 
compared in 35 subjects. The within-assay coefficient of variation 
(CV) was 1.2% for an HbA1c level of 5.1% and 4.3% for an HbA1c 
level of 12.9%. The between-assay CV was 2.4% and 3.2% for the two 
reference levels, respectively (personal communication from MA van 
Rensburg).
Statistical analysis
Data were collated in a spreadsheet and analysed using Statistica 
version 12 (Dell, USA). Continuous data were analysed descriptively 
using means and standard deviations with 95% confidence intervals 
(CIs) to estimate the true population mean. Frequency distributions 
were used to describe ordinal and nominal data. A significance level 
of p<0.05 was applied throughout.
The primary objective was to compare variables between the 
four treatment periods. As the same patient was observed in 
more than one period, the observations between periods for a 
particular patient are dependent. The Friedman analysis of variance 
(ANOVA) was therefore used to compare changes between the 
different periods. However, owing to missing data, recruitment 
over time and patient dropout, there were only a few patients who 
had observations in all four periods for all variables. Combinations 
of the periods were therefore tested. Periods P1, P2 and P3 were 
compared using Friedman’s ANOVA, as were P2, P3 and P4. 
Box-and-whisker plots were used to illustrate these comparisons 
graphically.
For all other comparisons of continuous variables between two 
groups, the Mann–Whitney U test was used, and for more than two 
groups the Kruskal–Wallis ANOVA was applied. Comparison of 
two nominal variables was performed using a chi-square test and a 
Fisher’s exact test for the 2x2 contingency tables. HbA1c levels were 
compared against sex and LJM (including the interaction) using 
multiple regression (this comparison was necessary because of a sex 
difference in the prevalence of LJM).
Ethical approval
Ethical approval was obtained from the Health Research Ethics 
Committee at Stellenbosch University (ref. no. N11/09/273).
Results
The records of 190 paediatric and adolescent T1DM patients were 
assessed over the four periods. In each period, new patients were 
diagnosed, others were lost to follow-up and some were transferred 
to the adult service. Not every patient was seen during every period, 
resulting in varying patient numbers per period. Patient numbers 
increased cumulatively over time: we saw 77 patients in P1 and 139 
patients in P4. Ethnic or gender composition of the sample (Table 
1) did not affect the outcome of the statistical analysis, except with 
regard to LJM, found in 60% (95% CI 43.3 - 75.1) of boys and 37.5% 
(95% CI 26.4 - 50.0) of girls (p=0.0291). This difference was not 
related to worse glycaemic control in boys.
Table 1. Patient characteristics at study entry (N=190)
Characteristic n (%)
Age at diagnosis (years)*
<2 15 (8)
2 - 10 88 (46.3)
≥10 86 (45)
Age category organised according to gender 
(years)*
Boys <12 49 (25.8)
Boys >12 17 (8.9)
Girls <11 88 (46.3)





Mixed ancestry 143 (75.3)
Black 25 (13.2)
White 22 (11.6)
Types of insulin therapy*
Short-acting
Human soluble insulin 164 (86.8)
Rapid-acting insulin analogue 25 (13.2)
Longer-acting
NPH† insulin 181 (95.3)
Long-acting insulin analogue 9 (4.7)
*Data missing in one patient.
†Neutral protamine Hagedorn.
13        SAJCH     APRIL 2019    Vol. 13    No. 1
ARTICLE
Glycaemic control
The mean HbA1c level across all patients was 9.9% (95% CI 9.1 - 10.8) 
in P1, 11.7% (95% CI 10.9 - 12.6) in P2, 10.2% (95% CI 9.8 - 10.5) in 
P3 and 9.8% (95% CI 9.4 - 10.1) in P4 (Fig. 1). Only 22 patients had 
HbA1c data in all four periods. Their mean HbA1c levels followed 
a similar pattern over time, but were significantly different (p=0.02).
Number of hospital admissions
The number of admissions of the 34 patients seen in all four periods 
decreased progressively (p=0.01) (Fig. 2). Some were not admitted at all 
during a period, thereby reducing the mean number of admissions to <1. 
Diabetic ketoacidosis and recurrent diabetic 
ketoacidosis
The DKA rate improved progressively over the four periods, from 
32.5/100 patient years in P1 to 23.5/100 patient years in P4. A similar 
pattern was observed for the rDKA rate, which decreased from 18.8% 
in P1 to 9.6% in P4. More girls presented with rDKA.
Insulin therapy
Human soluble and neutral protamine Hagedorn (NPH) insulin were 
used most often, as these are more readily available in public hospitals 
(Table 1). The number of insulin injections per day increased over time 
(p=0.01) from 2.93 (95% CI 2.85 - 3.01) in P1 to 3.14 (95% CI 3.06 - 
3.23) in P4 (Fig. 3). Most patients received 3 injections per day, i.e. 63 
(87.5%) during P1 and 112 (81.8%) during P4. The number of patients 
managed on >4 insulin injections per day increased from two (2.8%) 
in P1 to 24 (17.5%) in P4, while the number treated with 2 insulin 
injections per day dropped from seven patients (9.7%) to one from P1 
to P4, respectively. 
In P1, the mean insulin dose was significantly higher (p=0.00) than 
in the other three periods (Fig. 4) for all patients. The dose dropped 
from a maximum of 1.19 (95% CI 1.08 - 1.31) units/kg/day in P1 to a 
minimum of 0.88 (95% CI 0.82 - 0.93) units/kg/day in P2. The dose was 
subsequently adjusted to 0.93 (95% CI 0.87 - 1.00) units/kg/day in P4. 
Complications
The number of patients with documented complications over the 
four periods was small, but increased gradually as the number 
being screened increased (Table 2). This is presumably due to initial 
underdetection. For example, in P1 the presence of LJM was not 
assessed and only a single lipogram was requested. Complication 
detection improved when an aide-memoire was implemented in 
P2. Owing to low numbers, statistical analysis of complications 
was not possible, except for microalbuminuria and LDL cholesterol 
levels. The UAC was similar throughout all periods, i.e. 3.2 (95% CI 
1.1 - 5.3), 3.4 (95% CI 0.3 - 6.5), 4.5 (95% CI 2.1 - 6.8) and 3.4 (95% 
CI 1.2-5.7) mg/mmol in P1, P2, P3 and P4, respectively. The LDL 
cholesterol level changed significantly from 3.4 (95% CI 3.0 - 3.8) 
mmol/L in P2 to 2.6 (95% CI 2.4 - 2.8) mmol/L in P3. LJM was 
shown not to be associated with HbA1c. Presence of retinopathy, all 
non-proliferative except for one case, was only documented in P3 
and P4. Only one case of neuropathy was diagnosed (in P4). 
Discussion
The improvement in HbA1c levels after the DCT had been 



























Fig. 1. HbA1c levels per period (N=22 per period).


























Fig. 2. Number of admissions per period (N=34 per period).

































Fig. 3. Number of insulin injections per day per period (N=190).
SE = standard error; CI = confidence interval.
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somewhat unexpected (Fig. 1). Resolution of the honeymoon period 
cannot account for this observation, because it would have occurred 
before the commencement of P2. However, in the unstudied period 
prior to P2, diabetes management was suboptimal because a full-
time diabetes specialist was not available for the last 8 months and 
inexperienced staff were tasked with diabetes care. After a paediatric 
endocrinologist was reappointed and the DCT had been introduced, 
mean HbA1c levels improved again, with a total decrease of close to 
2% being achieved. 
In line with the recommendations of the DCCT, all patients 
were converted to a regimen of at least 3 injections per day.[22] A 
significant drop in mean insulin dose, maintained over all periods, 
was observed. This drop may have been due to improved injection 
technique, therapy adherence and the introduction of a point-of-
care HbA1c analyser, which facilitated immediate management 
discussions with the families. A similar decrease in HbA1c levels 
was achieved in another study when a primary nurse educator 
implemented DCCT recommendations,[15] although the total daily 
dose had to be increased to achieve this effect. However, the effect 
of the DNE’s involvement may be hard to separate from that of 
changing to a multiple injection regimen. Maintaining the beneficial 
effect over the long term may be difficult: a 10-year study surveying 
the introduction of both a DCT and a multiple injection regimen at a 
higher dose showed no effect on median HbA1c levels.[19] 
Improved HbA1c levels reported in other studies after a DCT was 
introduced varied between 0% and 1.3%.[11,12-14,16,23-26] However, these 
studies are not comparable to ours, for several reasons. Firstly, the 
time span in those studies was considerably shorter than in ours (i.e. 
6  - 12 months v. 6 years). Secondly, most of those studies assessed 
the impact of a DCT or DNE on the glycaemic control of adults 
with type 2 diabetes, and this patient population is likely to respond 
differently to therapeutic interventions. Thirdly, the combined 
effect of the reintroduction of specialist services, the appointment 
of a DNE and the standardisation of treatment to a multiple-dose 
injection regime resulted in a greater HbA1c decrease in our study. 
Lastly, institutionalisation of poorly controlled patients in our study 
may also have contributed to the observed results. 
Despite the improvement, the attained glycaemic control is still far 
above the HbA1c target of 7.5% proposed by ISPAD.[5,6,27] However, 
metabolic control is expected to continue to improve over time. The 
observation that the mean HbA1c levels were similar in P1 and P4 
should not detract from the impact of introducing a DNE to the team. 
The marked difference in variability between the two periods may be 
attributed to the DNE’s effectiveness in reaching the group, as opposed 
to the restricted efforts of the paediatric endocrinologist alone.
In P4, 10 of the 11 girls (90.9%) and 7 of the 11 boys (63.6%) 
had reached puberty, a period known to be associated with poor 
glycaemic control. Insulin resistance and high insulin clearance 
usually necessitate a higher insulin dose.[28] Adolescents are also well 
known to be resistant to change.[16] Psychiatric disturbances, resulting 
in poor adherence and consequently poorer glycaemic control, 
are frequent. In a large study from Germany and Austria, median 
HbA1c levels in adolescents were found to be about 2% higher than 
in preschoolers.[29] In contrast, in the present study, children (mostly 
adolescents) from predominantly poor socioeconomic backgrounds 
achieved improved glycaemic control with even less variation on a 
lower insulin dose.
A steady decline in the number of hospital admissions (about 75%) 
was seen over the study period. This pattern mirrors the change seen 
in HbA1c levels and translates to cost saving for the hospital. So far, 
studies assessing the effectiveness of a DCT have concentrated on 
documenting the reduced duration of hospitalisation.[7-10] To our 
knowledge, only one study has previously assessed admission rates 
and found no effect on readmissions.[7] 
Table 2. Prevalence of complications
Complication P1, n/N (%) P2, n/N (%) P3, n/N (%) P4, n/N (%)
Microalbuminuria* 8/22 (36.4) 7/25 (28.0) 30/65 (46.2) 18/67 (26.9)
Retinopathy 0/25 (0.0) 0/34 (0.0) 6/45 (13.3) 6/58 (10.3)
Neuropathy 0/26 (0.0) 0/39 (0.0) 0/79 (0.0) 1/88 (1.1)
LJM† - 13/50 (26.0) 36/89 (40.4) 42/98 (42.9)
High TSC‡ 6/35 (17.1) 4/30 (13.3) 10/63 (15.9) 11/64 (17.2)
High LDLC§ 1/1 (100) 4/19 (21.1) 5/61 (8.2) 5/42 (11.9)
Poor HDLC¶ 0/1 (0.0) 1/19 (5.3) 12/63 (19.0) 10/43 (23.3)
High TG|| 0/1 (0.0) 0/19 (0.0) 4/64 (6.3) 5/44 (11.4)
P1 = August 2004 - July 2005; P2 = August 2007 - July 2008; P3 = August 2009 - July 2010; P4 = September 2010 - July 2011. 
UAC = urine albumin–creatinine; LJM = limited joint mobility; TSC = total serum cholesterol; LDLC = low-density lipoprotein cholesterol; HDLC = high-density lipoprotein 
cholesterol; TG = triglycerides.
*Defined as UAC >2 mg/mmol in two consecutive early-morning urine samples. 
† Not assessed in P1.
‡ >6.2 mmol/L. 
§ ≥4.1 mmol/L. 

































Fig. 4. Insulin dose per day per period (N=190).
SE = standard error; CI = confidence interval.
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The decreasing admission rate seen in the present study further 
attests to the effectiveness of a full DCT. Patients were mainly 
admitted because they developed DKA. As shown earlier, the DKA 
rate decreased in each period, affecting overall admission rates. The 
number of rDKA admissions also improved. A decrease in rDKA rate 
generally would not be expected, because children presenting with 
rDKA frequently have underlying social or behavioural pathology 
not amenable to intervention. However, a drop in the rDKA rate 
was probably achieved because patients were being institutionalised 
once the pathology had been detected. To our knowledge, such a 
reduction in DKA rates has not been demonstrated before. 
Although HbA1c levels improved progressively over time, the 
prevalence of microalbuminuria did not change accordingly. Other 
studies suggest that a longer period of observation may be required 
for any effect on renal function to manifest. For example, it took 10 
years before a 50% difference in nephropathy prevalence could be 
demonstrated in adult T1DM patients managed by diabetologists 
over those managed by generalists.[17] A similar reduction was 
achieved in diabetic adolescents 5 years after DCT institution and 
implementation of DCCT recommendations.[19,20] 
Over time, LJM was more commonly recognised, with an actual 
prevalence of about 40%. In other studies, the reported prevalence 
of LJM ranges from 3.9% - 55%. This wide range probably relates to 
examination technique, the age of the population and the duration of 
diabetes.[30] As in other studies, an association between HbA1c levels 
and the occurrence of LJM could not be established. 
Triglyceride levels remained constant during the assessed periods. 
A decrease in LDL cholesterol levels was seen in the short term, 
which probably reflects better glycaemic control. Similar changes, 
together with improved HDL cholesterol levels, were seen in another 
study following the introduction of a mobile DCT for adult type 2 
diabetes patients.[12] 
Circumstantial evidence suggests that many patients did not 
attend their ophthalmology appointments before the introduction 
of fundal photography in P4, which may explain why no retinopathy 
was identified during the first two periods. The actual prevalence 
may therefore be higher than what was observed. Presumably this is 
also true for neuropathy, as only one patient was identified after four 
periods. Inadequate screening is not unique to this service.[8] Both 
adult and paediatric literature suggest that the prevalence of these 
two complications is 12% at best,[8,18,19] i.e. considerably higher than 
what was observed in the current study. Efforts to detect all possible 
complications therefore need to be intensified. Furthermore, a 
prospective study would be more effective in detecting complications.
The limitations alluded to here are typical of any retrospective 
study. For example, some patients may have escaped repeat testing 
for microalbuminuria, which may have artificially inflated the 
microalbuminuria rate and could consequently have been interpreted 
as a lack of improvement. Data on the duration of the honeymoon 
period or the duration of illness, puberty and body mass index, all 
of which could have affected glycaemic control, were not collected. 
However, a significant improvement in HbA1c levels was seen over 
time, suggesting that these factors were fairly inconsequential. As 
about a quarter of our patient population resides in rural areas, 
patients who had developed DKA could have presented at peripheral 
hospitals, resulting in under-reporting of the DKA rate at our centre. 
This bias should, however, be fairly constant across all periods.
Conclusion
A significant improvement in glycaemic control of paediatric and 
adolescent T1DM patients from a lower socioeconomic background 
was achieved in a resource-poor environment by re-establishing 
specialist care and introducing a full DCT. Switching all patients 
to a multiple-dose injection regimen probably contributed to the 
improvement. Low variation in HbA1c levels was achieved in 
predominantly pubertal patients at a lower daily insulin dose. The 
effect of improved metabolic control was mirrored by a reduction in 
admission and DKA rates over time, confirming the value of a DCT 
in the management of T1DM patients. 
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